What question did this study set out to answer?

To evaluate the efficacy of a tailored pharmaceutical care intervention on health-related quality of life in individuals with COPD.

January 18, 2026JMIR Research ProtocolsOpen Access

Evaluation of a Tailored Multifaceted Pharmaceutical Care Intervention to Optimize Chronic Obstructive Pulmonary Disease Management: Protocol for a Cluster Randomized Controlled Trial

View Full Paper

Ask AI

Bookmark

Authors

A cluster randomized controlled trial assesses a multifaceted intervention’s impact on quality of life and adherence in individuals with COPD.

To evaluate the efficacy of a tailored pharmaceutical care intervention on health-related quality of life in individuals with COPD.
Conducted a 1-year cluster randomized controlled trial in adults with moderate to very severe COPD.
Participants were matched to appropriate inhaler devices based on digital assessments.
Intervention group received tailored support including adherence monitoring and inhaler technique assessments.
Control group received usual pharmaceutical care.
Used linear mixed effects models for outcome comparisons.
Recruitment of 454 participants completed by December 31, 2025.
Only 16 participants (3.5%) completed the 12-month follow-up as of enrollment completion.
Trial findings expected to enhance COPD management and HRQoL post-completion in December 2026.

Ma et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

A cluster randomized controlled trial assesses a multifaceted intervention’s impact on quality of life and adherence in individuals with COPD.